Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,584.00    18.00 (0.39%)
Bid:
4,582.00
Ask:
4,586.00
Spread: 4.00 (0.087%)
Market Cap: £16.71b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Directorate Change

21 Jun 2017 09:26

RNS Number : 7109I
Coca-Cola HBC AG
21 June 2017
 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Composition of the Committees of the Board of Directors of Coca‑Cola HBC AG and determination of a new member of the Board of Directors of Coca‑Cola HBC AG

 

 

Zug, Switzerland - 21 June 2017 - Coca‑Cola HBC AG ("Coca‑Cola HBC" or the "Company") announces today that its board of directors (the "Board") has appointed Ms. Charlotte J. Boyle as a member of the Remuneration Committee, with effect from 20 June 2017.

This appointment has been made pursuant to the announcement released by Coca‑Cola HBC on 15 May 2017 and the election of Ms. Charlotte J. Boyle as a non-executive member of the Board at the Company's annual general meeting held on 20 June 2017, following the retirement of Mr. Antonio D'Amato.

The Board has determined that Ms. Charlotte J. Boyle qualifies as independent under the criteria set forth in the UK Corporate Governance Code.

Aside from the information set out above, no further information is required to be disclosed pursuant to the UK Financial Conduct Authority's Listing Rule 9.6.13 and the new non-executive director does not hold any interests in the shares of Coca‑Cola HBC.

The composition of the Board Committees will be as follows:

Audit Committee

William (Bill) W. Douglas III (Chair)

John P. Sechi

Olusola (Sola) David-Borha

Nomination Committee

Reto Francioni (Chair)

Charlotte J. Boyle

Alexandra Papalexopoulou

Remuneration Committee

Alexandra Papalexopoulou (Chair)

Charlotte J. Boyle

Reto Francioni

Social Responsibility Committee

Anastasios I. Leventis (Chair)

Alexandra Papalexopoulou

José Octavio Reyes

This announcement is made pursuant to Listing Rule 9.6.11.

 

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +44 20 37 444 231 basak.kotler@cchellenic.com

Vasso Aliferi

Investor Relations Manager

Tel: +30 210 6183 341

vasso.aliferi@cchellenic.com

Maria Livaniou

Head of Shareowner Service

Tel: +30 210 6183 106

maria.livaniou@cchellenic.com

 

International media contact:

Teneo Blue Rubicon

Rob Morgan

Anushka Mathew

Tel: +44 20 7260 2700 robert.morgan@teneobluerubicon.com anushka.mathew@teneobluerubicon.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with a sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 595 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked beverage industry leader in the Dow Jones Sustainability World and Europe Indices, and is also included in the FTSE4Good Index.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALIFFTRSILFID
Date   Source Headline
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding
17th Dec 20257:00 amRNSNotice of EGM
24th Nov 20252:15 pmRNSDirector/PDMR Shareholding
18th Nov 20254:10 pmRNSDirector/PDMR Shareholding
5th Nov 20251:45 pmRNSDirector/PDMR Shareholding
3rd Nov 20259:30 amRNSBlock listing Interim Review
30th Oct 20253:00 pmRNSHolding(s) in Company
23rd Oct 20252:10 pmRNSDirector/PDMR Shareholding
23rd Oct 20252:00 pmRNSDirector/PDMR Shareholding
21st Oct 20257:03 amRNSSolid Q3 performance; guidance reiterated
21st Oct 20257:00 amRNSCCH to acquire Coca-Cola Beverages Africa
20th Oct 20253:45 pmRNSDirector/PDMR Shareholding
30th Sep 202511:30 amRNSNotice of Results
18th Sep 20252:30 pmRNSDirector/PDMR Shareholding
19th Aug 202512:00 pmRNSDirector/PDMR Shareholding
6th Aug 20257:00 amRNSConsistent execution delivers strong H1 results
4th Aug 20254:45 pmRNSRevolving Credit Facility
18th Jul 202512:15 pmRNSDirector/PDMR Shareholding
15th Jul 20251:00 pmRNSBitesize Investor Series – Nigeria
7th Jul 20251:09 pmRNSNotice of Results
3rd Jul 202510:04 amRNSHolding(s) in Company
2nd Jul 20253:29 pmRNSHolding(s) in Company
30th Jun 20253:32 pmRNSDirector/PDMR Shareholding
30th Jun 20251:44 pmRNSHolding(s) in Company
18th Jun 20252:55 pmRNSDirector/PDMR Shareholding
3rd Jun 20251:19 pmRNSDirector/PDMR Shareholding
2nd Jun 20258:07 amRNSTransfer of treasury shares & total voting rights
23rd May 20252:05 pmRNSComposition of the Board Committees
23rd May 20251:55 pmRNSResult of AGM and dividend dates
20th May 20252:37 pmRNSDirector/PDMR Shareholding
19th May 202512:22 pmRNSDirector/PDMR Shareholding
7th May 20252:33 pmRNSDirector/PDMR Shareholding
1st May 20259:37 amRNSBlock listing Interim Review
1st May 20259:23 amRNSTransfer of treasury shares & total voting rights
30th Apr 20257:00 amRNSStrong start; reiterating 2025 guidance
23rd Apr 20251:38 pmRNSAGM Notice,changes to BoD,dividend dates-Amendment
23rd Apr 20257:00 amRNSNotice of AGM, changes to the BoD, dividend dates
22nd Apr 202512:42 pmRNSDirector/PDMR Shareholding
2nd Apr 202510:13 amRNSNotice of Results
1st Apr 20259:23 amRNSTransfer of treasury shares & total voting rights
28th Mar 20252:43 pmRNSDirector/PDMR Shareholding
28th Mar 20252:42 pmRNSDirector/PDMR Shareholding
28th Mar 20252:37 pmRNSDirector/PDMR Shareholding
19th Mar 20254:47 pmRNSDirector/PDMR Shareholding - Amendment
19th Mar 20254:43 pmRNSDirector/PDMR Shareholding - Amendment
19th Mar 20251:40 pmRNSDirector/PDMR Shareholding
19th Mar 20251:33 pmRNSDirector/PDMR Shareholding
19th Mar 20251:30 pmRNSDirector/PDMR Shareholding
19th Mar 20251:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.